tert-Butyl ((3R,4S)-4-aminotetrahydrofuran-3-yl)carbamate

Catalog No. :
ACFKYP698
CAS No. :
1628794-75-1
Molecular Formula :
C9H18N2O3
Molecular Weight :
202.25

IUPAC Name:tert-butyl ((3R,4S)-4-aminotetrahydrofuran-3-yl)carbamate

tert-Butyl ((3R,4S)-4-aminotetrahydrofuran-3-yl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$87.00Login to see priceIn stockInquiry
250mg95%$140.00Login to see priceIn stockIn stock
1g95%$348.00Login to see priceIn stockIn stock
5g95%$1210.00Login to see priceIn stockIn stock
25g95%$4726.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl ((3R,4S)-4-aminotetrahydrofuran-3-yl)carbamate
IUPAC Nametert-butyl ((3R,4S)-4-aminotetrahydrofuran-3-yl)carbamate
MDL No.MFCD27956984
Molecular FormulaC9H18N2O3
Molecular Weight202.25
SMILESO=C(OC(C)(C)C)N[C@H]1COC[C@H]1N
InChI KeyHWYDCYLRWDJCCH-RQJHMYQMSA-N
Synonymtert-butyl ((3R,4S)-4-aminotetrahydrofuran-3-yl)carbamate | 1628794-75-1 | 1629586-23-7 | 3-N-Boc-cis-tetrahydrofuran-3,4-diamine | TERT-BUTYL N-[(3R,4S)-4-AMINOOXOLAN-3-YL]CARBAMATE | tert-Butyl (cis-4-aminotetrahydrofuran-3-yl)carbamate | MFCD27956984 |
CAS No.1628794-75-1
PubChem CID90436776

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACFKYP698 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFKYP698 route product structure diagram
    ACFKYP6981628794-75-1 In Stock
Inquiry

2. ACFKYP698 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFKYP698 route product structure diagram
    ACFKYP6981628794-75-1 In Stock
Inquiry

Comments (0)